Search Results 81-90 of 16562 for Valproate

  1. Optimizing Pharmacotherapy in Epilepsy using Seizure Forecasts via EEG and Wearables - Mayo Clinic

    Subject has significant platelet dysfunction from medical conditions or medications (including, particularly, aspirin or sodium valproate). If platelet ...

  2. Drugs and Supplements that Start with L - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “L” to learn about drug side effects, proper use and ...

  4. Piroxicam (oral route) - Mayo Clinic

    Piroxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and help relieve symptoms of arthritis (eg, osteoarthritis, rheumatoid arthritis), ...

  5. Clobazam (oral route) - Side effects & dosage - Mayo Clinic

    Clobazam is a benzodiazepine. Benzodiazepines belong to the group of medicines called central nervous system (CNS) depressants, which are medicines that slow ...

  6. Olaratumab (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  7. Bupivacaine (implantation route) - Side effects & uses - Mayo Clinic

    Bupivacaine implant is used to prevent pain for up to 24 hours after surgery in the groin area (open inguinal hernia repair). It is a local anesthetic.

  8. Afamitresgene autoleucel (intravenous route) - Side effects & uses - Mayo Clinic

    Afamitresgene autoleucel injection is an antineoplastic (cancer) medicine that is made from your own white blood cells, which have been modified to recognize ...

  9. The Food and Drug Administration (FDA) approved these atypical antidepressants to treat depression: Bupropion (Wellbutrin SR, Wellbutrin XL, others) ...

  10. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

    The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist, in ...